Fighting cervical cancer: Eckert & Ziegler wins World Bank tender to provide equipment for cancer clinics in Bangladesh

Berlin, (PresseBox) - Eckert & Ziegler Strahlen- und Medizintechnik has won a tender in Bangladesh through its subsidiary Eckert & Ziegler BEBIG to equip Bangladeshi cancer clinics with modern cancer irradiation equipment. The devices from the MultiSource® series worth €3.1 million will provide clinics with a full range of options for efficiently treating gynecological tumors, with a focus on healing cervical cancer, across the whole of East Bengal. Bangladesh has one of the world's highest mortality rates from this type of malignant tumor. There are still few hospitals where women with cancer can be effectively treated.

"We are particularly proud of this order," said Abel Luzuriaga, Member of the Executive Board and responsible for the medical device division at Eckert & Ziegler. "We have provided the first clinics in Bangladesh with equipment several years ago and have now received a subsequent order for deliveries on a large scale. Even if the order volume doesn't seem all that large at first, the devices will make a significant difference to the lives of tens of thousands of women - and their children. Cervical cancer often occurs at a relatively young age and in many cases affects mothers."

The MultiSource® line of cancer irradiation equipment with integrated planning software became the most opted equipment and was chosen on account of its long use of miniaturized cobalt-60 technology, which is unrivaled in the market. They offer a high degree of flexibility and versatility and a cost-effective solution for treating cancer. The devices operate at about a sixth of the cost of conventional systems.

"We are pleased to see that emerging countries in Asia, Africa and South America are increasingly gaining access to the latest medical infrastructure that has long been available in other parts of the world. Of course, these countries have to think twice before they invest. Our range of MultiSource® devices is exactly what decision-makers are looking for," Luzuriaga added, "which is clearly the reason they have ordered more."

In the last few years, Eckert & Ziegler has already equipped more than 250 cancer clinics with these systems, and even nationwide in some countries. The equipment is scheduled for delivery to Bangladesh Government radiation clinics between December 2013 and March 2014.

The order is being funded by a consortium that includes the World Bank, the World Health Organization, the EU and the KfW Development Bank as part of the Health, Population & Nutrition Sector Development Program. The goal of the five-year program is to guarantee basic health care for the treatment of new cancer cases, which are on the rise in Bangladesh.

Eckert & Ziegler Strahlen- und Medizintechnik AG

With around 670 employees, the Eckert & Ziegler Group (ISIN DE0005659700) is one of the world's largest providers of isotope components for radiation therapy and nuclear medicine. Besides irradiation equipment for gynecological cancers, Eckert & Ziegler manufactures special products for the treatment of prostate cancer and ocular tumors.

Press releases you might also be interested in

Weitere Informationen zum Thema "Medizintechnik":

Intel zeigt Ausblick auf die künstliche Intelligenz von morgen

Wel­che Ve­r­än­de­run­gen, die künst­li­che In­tel­li­genz zu­künf­tig für uns al­le brin­gen wird, konn­te man in die­sem Jahr auf der größ­ten Kon­su­men­ten-Elek­tro­nik­mes­se der Welt, der CES in Las Ve­gas se­hen. Auch am Stand von In­tel gab es vie­les zu se­hen. An­ge­fan­gen vom Au­to­no­men Fah­ren, bis hin zu den Mög­lich­kei­ten, die die Vir­tu­el­le Rea­li­tät bie­tet

Weiterlesen

Subscribe for news

The subscribtion service of the PresseBox informs you about press information of a certain topic by your choice at a choosen time. Please enter your email address to receive the email with the press releases.

An error occurred!

Thank you! You will receive a confirmation email within a few minutes.


I want to subscribe to the gratis press mail and have read and accepted the conditions.